Source map — Amylyx Stock Surges 55% After GLP-1 Blocker Hits All Trial Goals
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| Barron's | news | 60% |
| Reuters | news | 60% |
| Endpoints News | news | 60% |
| Yahoo Finance | news | 60% |
| STAT | news | 60% |
| Fierce Biotech | news | 60% |